2 Bill Gates MerckInc Trades
Bill Gates started to build up the position in MerckInc in Q3 2023. Since then they sold 17.7 Thousand shares. The investor sold all their shares in Q4 2023 and doesn't own any shares in MerckInc anymore.
Avg closing price
Price range
Sold -17.7 Thousand shares
Q4 2023
Avg closing price
$103.80
Price range
$100.18
-
$109.02
New holding (+17.7 Thousand shares)
Q3 2023
Avg closing price
$107.78
Price range
$102.95
-
$114.33
News about Merck & Co Inc and Bill Gates
Covid pill: Gates Foundation allots $120 mln for poor nations to get Covid-19 drug
Oct 20 (Reuters) - The Gates Foundation will allocate up to $120 million to help lower-income countries get an experimental Covid-19 drug being developed by ...
Gates Foundation awards $122 million for trial of monthly HIV pill
The grant to the University of Washington School of Medicine will support the implementation of a Phase 3 randomized trial of islatravir a nucleoside revers...